We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNYSE:OPK
Date6/2007
Raised
Post IPO Valuation

General Information

Websiteopko.com
CategoryBioTech
Phone(305) 575-4100
Employees

Offices

Miami, USA
4400 Biscayne Blvd.
Miami, FL, 33137
USA

People

Acquisitions

Total$11.9M
Inspiro Medical, 4/2014 $10M
PROLOR Biotech, 4/2013
Cytochroma, 1/2013
Claros Diagnostics, 10/2011
Vidus Ocular, 5/2008 $1.89M

Investments

Fabrus 11/2010

Funding

TOTAL $31M
FUNDING TOTAL $31M
Venture Round, 6/2009
$31M
DEBT TOTAL $175M
Debt, 2/2013
$175M

Tags

OPKO Health

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging its discovery, development, and commercialization expertise and its novel and proprietary technologies. The company intends to leverage its global commercialization expertise to pursue acquisitions of commercial businesses that will both drive growth and provide geographically diverse sales and distribution opportunities. OPKO has and may continue to make investments in other early stage companies that the company perceives to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder.

Recent Milestones

Videos

Screenshots

OPKO Health screenshot
Above: Homepage
Uploaded: 6/20/13

Stock Price

Sources

  1. Pharma company Opko acquires smart inhaler startup for at least $10M (mobihealthnews.com) [edit]
  2. OPKO Health To Acquire PROLOR Biotech (finance.yahoo.com) [edit]
  3. OPKO Health to acquire privately held Cytochroma (prnewswire.com) [edit]
  4. OPKO Health Announces Acquisition of Claros Diagnostics (investor.opko.com) [edit]
  5. Opko Health buys Vidus Ocular (southflorida.bizjournals.com) [edit]
  6. Fabrus Raises $2M (finsmes.com) [edit]
  7. SEC (sec.gov) [edit]
  8. SEC (sec.gov) [edit]
  9. OPKO Health Completes Acquisition of NK-1 Compounds from Schering Corporation (investor.opko.com) [edit]
Edit This Page
Last Edited 4/17/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy